These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3925894)

  • 1. Lymphocyte subset ratios and factor VIII usage in haemophilia.
    Beddall AC; Al-Rubei K; Williams MD; Hill FG
    Arch Dis Child; 1985 Jun; 60(6):530-6. PubMed ID: 3925894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate.
    Smid WM; van der Meer J; Smit JW; Halie MR
    Thromb Haemost; 1993 Apr; 69(4):306-10. PubMed ID: 8388579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized lymphadenopathy and T cell abnormalities in hemophilia A.
    Gill JC; Menitove JE; Wheeler D; Aster RH; Montgomery RR
    J Pediatr; 1983 Jul; 103(1):18-22. PubMed ID: 6223133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence and progression of immunologic abnormalities in haemophilia.
    Gill JC; Wheeler D; Menitove JE; Aster RH; Casper JT; Kirchner P; Montgomery RR
    Thromb Haemost; 1985 Jun; 53(3):328-31. PubMed ID: 3931282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered immunity in haemophiliacs treated exclusively with cryoprecipitate.
    Tien SL; Ong YW; Tan P; Tan H
    Ann Acad Med Singap; 1993 Mar; 22(2):242-6. PubMed ID: 8363341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy.
    Cuthbert RJ; Ludlam CA; Steel CM; Beatson D; Peutherer JF
    Br J Haematol; 1992 Mar; 80(3):364-9. PubMed ID: 1581216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia.
    Shannon BT; Roach J; Cheek-Luten M; Orosz C; Ruymann FB
    J Clin Immunol; 1986 Mar; 6(2):121-9. PubMed ID: 3086364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of lymphocyte populations and subpopulations in hemophiliacs and their relationships with age and consumption of lyophilized factor VIII concentrates.
    Aznar JA; Carbonell F; Jorquera JI; Carmona E; Sánchez-Cuenca JM; Trénor A; de Andrés-Medina R; González-Molina A
    Ric Clin Lab; 1985; 15(4):315-21. PubMed ID: 3938863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
    Shannon BT; Roach J; Cheek-Luten M; Ruymann FB
    Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
    Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
    Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological alterations in haemophiliacs treated with lyophilized Factor VIII cryoprecipitate from volunteer donors.
    Ceuppens JL; Vermylen J; Colaert J; Desmyter J; Gautama K; Stevens E; The AL; Vanham G; Vermylen C; Verstraete M
    Thromb Haemost; 1984 Apr; 51(2):207-11. PubMed ID: 6429883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between blood product exposure and immunological abnormalities in English haemophiliacs.
    Lee CA; Bofill M; Janossy G; Thomas HC; Rizza CR; Kernoff PB
    Br J Haematol; 1985 May; 60(1):161-72. PubMed ID: 3890927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of clinical and immunological abnormalities in haemophilia A to F VIII therapy and HIV exposure: a longitudinal study.
    Eagleton MC; Whelan CA; Sarsfield P; Carr B; Temperley IJ; Feighery C
    Eur J Haematol; 1988 Jan; 40(1):35-41. PubMed ID: 2963754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?
    Froebel KS; Madhok R; Forbes CD; Lennie SE; Lowe GD; Sturrock RD
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1091-3. PubMed ID: 6226334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immunity in Brazilian hemophilia patients.
    Falcão RP; Ismael SJ; Voltarelli JC
    Braz J Med Biol Res; 1986; 19(1):137-9. PubMed ID: 3801725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of cell mediated and humoral immunity in haemophilia and related disorders.
    Moffat EH; Bloom AL; Jones J; Matthews N; Newcombe RG
    Br J Haematol; 1985 Sep; 61(1):157-67. PubMed ID: 3931666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV-III antibody and T-cell subset ratios in haemophiliacs and their spouses.
    McVerry BA; Machin SJ; Galloway MJ; McCarthy K; Evans P; Barnes RM; Turner GC; Cheingsong-Popov R; Tedder RS; Winter M
    Br J Haematol; 1986 Jun; 63(2):347-52. PubMed ID: 3013274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of lymphocyte subsets and anti-LAV/HTLV-III status in Greek hemophiliacs.
    Choremi H; Economidou J; Psarra K; Sidiri E; Mandalaki T; Louizou C; Gialeraki A; Markakis C; Papaevangelou C; Kallinicos G
    AIDS Res; 1986; 2(4):271-7. PubMed ID: 3101712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status.
    Seremetis SV; Aledort LM; Bergman GE; Bona R; Bray G; Brettler D; Eyster ME; Kessler C; Lau TS; Lusher J
    Lancet; 1993 Sep; 342(8873):700-3. PubMed ID: 8103820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.